Scinai Immunotherapeutics
€3.98
18
+€0.00+0% Friday 13:29
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
2.7M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Financials
-633.91%Profit Margin
Unprofitable1.11MRevenue
-7.06MNet Income
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Scinai Immunotherapeutics Ltd., a development stage biopharmaceutical company, focuses on developing, manufacturing, and commercializing products for the prevention and treatment of infectious and autoimmune diseases, and other illnesses in Israel. It has licensing and collaboration agreement with Max Planck Society and University Medical Center Göttingen for the development and commercialization of COVID-19 nanosized antibody (NanoAb); and development and commercialization of NanoAbs for various other disease indications. The company was formerly known as BiondVax Pharmaceuticals Ltd. and changed its name to Scinai Immunotherapeutics Ltd. in September 2023. Scinai Immunotherapeutics Ltd. was incorporated in 2003 and is headquartered in Jerusalem, Israel.
Show more...
CEO
Mr. Amir Reichman M.B.A., M.Sc.
Employees
45
Country
Israel
ISIN
US09073Q4029
WKN
000A42JHP
Listings
0 Comments
Share your thoughts
FAQ
What is Scinai Immunotherapeutics stock price today?▼
The current price of 2F50.F is €3.98 EUR — it has increased by +0% in the past 24 hours. Watch Scinai Immunotherapeutics stock price performance more closely on the chart.
What is Scinai Immunotherapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange Scinai Immunotherapeutics stocks are traded under the ticker 2F50.F.
What is Scinai Immunotherapeutics market cap?▼
Today Scinai Immunotherapeutics has the market capitalization of 2.7M
What is Scinai Immunotherapeutics revenue for the last year?▼
Scinai Immunotherapeutics revenue for the last year amounts to 1.11M EUR.
What is Scinai Immunotherapeutics net income for the last year?▼
2F50.F net income for the last year is -7.06M EUR.
How many employees does Scinai Immunotherapeutics have?▼
As of September 03, 2026, the company has 45 employees.
In which sector is Scinai Immunotherapeutics located?▼
Scinai Immunotherapeutics operates in the Health & Wellness sector.
When did Scinai Immunotherapeutics complete a stock split?▼
The last stock split for Scinai Immunotherapeutics was on August 21, 2026 with a ratio of 1:10.
Where is Scinai Immunotherapeutics headquartered?▼
Scinai Immunotherapeutics is headquartered in JERUSALEM, Israel.